Profil
Saskia van Walsum is currently the Chairman-Supervisory Board at Spar Holding BV since 2015.
Prior to this, she worked as the Director at CF Management Rotterdam BV from 2012 to 2018.
She also served as a Member-Supervisory Board at Micreos BV.
Postes actifs de Saskia van Walsum
| Sociétés | Poste | Début |
|---|---|---|
Spar Holding BV
Spar Holding BV Food RetailRetail Trade Operates a supermarket chain | Président | 01/09/2015 |
Anciens postes connus de Saskia van Walsum
| Sociétés | Poste | Fin |
|---|---|---|
CF Management Rotterdam BV
CF Management Rotterdam BV Investment ManagersFinance CF is an active, long-term manager which seeks growth opportunities across a broad range of sectors primarily in unlisted mid-sized firms located in The Netherlands, in addition to Belgium, Luxembourg and Germany for MPF. They do not invest in start-up firms or in businesses that have operating losses. The firm seeks transaction profits by buying and selling participating interests in established mid-sized firms having operated for a minimum of two complete fiscal years. They focus on profitable firms with a clear growth strategy and with minimum revenues of EUR 5 million. They avoid investments in sectors such as weapons, hospitality, real estate, insurance and forward trading. At the start of each venture, an exit strategy is established by the portfolio firm's management team. The investment horizon is generally three to five years. The CF investment strategy seeks a balanced portfolio risk. They focus on LBOs with a preference for majority stakes. Investment sizes range from EUR 500 thousand to EUR 12 million. They look for profitable firms requiring additional financing for growth through acquisitions, value creation, marketing and optimization of processes. They typically target eight to 12 portfolio holdings. Their exit strategy is generally from three to five years. | President | 01/12/2018 |
Micreos BV
Micreos BV Pharmaceuticals: MajorHealth Technology Operates as a biotech platform company that develops recombinant proteins for chronic dermatology conditions | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Micreos BV
Micreos BV Pharmaceuticals: MajorHealth Technology Operates as a biotech platform company that develops recombinant proteins for chronic dermatology conditions | Health Technology |
CF Management Rotterdam BV
CF Management Rotterdam BV Investment ManagersFinance CF is an active, long-term manager which seeks growth opportunities across a broad range of sectors primarily in unlisted mid-sized firms located in The Netherlands, in addition to Belgium, Luxembourg and Germany for MPF. They do not invest in start-up firms or in businesses that have operating losses. The firm seeks transaction profits by buying and selling participating interests in established mid-sized firms having operated for a minimum of two complete fiscal years. They focus on profitable firms with a clear growth strategy and with minimum revenues of EUR 5 million. They avoid investments in sectors such as weapons, hospitality, real estate, insurance and forward trading. At the start of each venture, an exit strategy is established by the portfolio firm's management team. The investment horizon is generally three to five years. The CF investment strategy seeks a balanced portfolio risk. They focus on LBOs with a preference for majority stakes. Investment sizes range from EUR 500 thousand to EUR 12 million. They look for profitable firms requiring additional financing for growth through acquisitions, value creation, marketing and optimization of processes. They typically target eight to 12 portfolio holdings. Their exit strategy is generally from three to five years. | Finance |
Spar Holding BV
Spar Holding BV Food RetailRetail Trade Operates a supermarket chain | Retail Trade |
















